![20 Years Later, Glioblastoma Brain Cancer Survivor Continues To Thrive — Glioblastoma Research Organization 20 Years Later, Glioblastoma Brain Cancer Survivor Continues To Thrive — Glioblastoma Research Organization](https://images.squarespace-cdn.com/content/v1/634d7831639a771f97ecb4d2/1674489813289-MK18ZULU2IV90IG853JO/David+Fitting+20+Year+Glioblastoma+Brain+Cancer+Diagnosis+Survivor.jpeg)
20 Years Later, Glioblastoma Brain Cancer Survivor Continues To Thrive — Glioblastoma Research Organization
![Frontiers | A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution Frontiers | A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution](https://www.frontiersin.org/files/Articles/597587/fonc-11-597587-HTML/image_m/fonc-11-597587-g001.jpg)
Frontiers | A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution
![Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics | Acta Neurochirurgica Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics | Acta Neurochirurgica](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00701-023-05544-3/MediaObjects/701_2023_5544_Fig3_HTML.png)
Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics | Acta Neurochirurgica
![PDF) Long-term survival in glioblastoma: Methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor PDF) Long-term survival in glioblastoma: Methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor](https://www.researchgate.net/profile/Mara-Popovic/publication/284122057/figure/fig3/AS:670442431979523@1536857340113/Survival-of-glioblastoma-patients_Q320.jpg)
PDF) Long-term survival in glioblastoma: Methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor
![Long-Term Survival of a Patient with Glioblastoma | Canadian Journal of Neurological Sciences | Cambridge Core Long-Term Survival of a Patient with Glioblastoma | Canadian Journal of Neurological Sciences | Cambridge Core](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0317167100010118/resource/name/firstPage-S0317167100010118a.jpg)
Long-Term Survival of a Patient with Glioblastoma | Canadian Journal of Neurological Sciences | Cambridge Core
![Cancers | Free Full-Text | Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM) Cancers | Free Full-Text | Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)](https://pub.mdpi-res.com/cancers/cancers-15-02116/article_deploy/html/images/cancers-15-02116-ag.png?1680840824)
Cancers | Free Full-Text | Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
![Frontiers | The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma Frontiers | The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma](https://www.frontiersin.org/files/Articles/447805/fphar-10-00200-HTML/image_m/fphar-10-00200-g001.jpg)
Frontiers | The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma
![Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma | Scientific Reports Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-18310-0/MediaObjects/41598_2017_18310_Fig1_HTML.jpg)
Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma | Scientific Reports
![Three Survivors of Glioblastoma Brain Cancer Celebrate 10 Years of Life Post-Diagnosis | Henry Ford Health - Detroit, MI Three Survivors of Glioblastoma Brain Cancer Celebrate 10 Years of Life Post-Diagnosis | Henry Ford Health - Detroit, MI](https://www.henryford.com/-/media/project/hfhs/henryford/news/2019/sasha-and-danielle---resized.jpg?rev=02e18eaf9c8b471b8008971910df0bcd)
Three Survivors of Glioblastoma Brain Cancer Celebrate 10 Years of Life Post-Diagnosis | Henry Ford Health - Detroit, MI
![Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy | Scientific Reports Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-67697-w/MediaObjects/41598_2020_67697_Fig1_HTML.png)
Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy | Scientific Reports
![Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma | Radiation Oncology | Full Text Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma | Radiation Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13014-019-1272-6/MediaObjects/13014_2019_1272_Fig1_HTML.png)
Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma | Radiation Oncology | Full Text
![Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics | Acta Neurochirurgica Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics | Acta Neurochirurgica](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00701-023-05544-3/MediaObjects/701_2023_5544_Fig2_HTML.png)
Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics | Acta Neurochirurgica
![First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide | Journal of Neuro-Oncology First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide | Journal of Neuro-Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11060-019-03339-0/MediaObjects/11060_2019_3339_Fig1_HTML.png)
First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide | Journal of Neuro-Oncology
![Analysis of Factors Associated with Long-Term Survival in Patients with Glioblastoma - ScienceDirect Analysis of Factors Associated with Long-Term Survival in Patients with Glioblastoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1878875021001340-fx1.jpg)